Quantbot Technologies LP Acquires 8,031 Shares of TriMas Co. (NASDAQ:TRS)

Quantbot Technologies LP boosted its holdings in shares of TriMas Co. (NASDAQ:TRSFree Report) by 203.5% in the fourth quarter, HoldingsChannel reports. The fund owned 11,978 shares of the industrial products company’s stock after acquiring an additional 8,031 shares during the period. Quantbot Technologies LP’s holdings in TriMas were worth $295,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of TRS. Intech Investment Management LLC bought a new stake in TriMas in the third quarter worth $269,000. Paloma Partners Management Co purchased a new position in shares of TriMas in the 3rd quarter worth about $293,000. XTX Topco Ltd bought a new position in TriMas in the 3rd quarter worth about $371,000. JPMorgan Chase & Co. grew its position in TriMas by 3.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 38,461 shares of the industrial products company’s stock valued at $982,000 after purchasing an additional 1,227 shares during the last quarter. Finally, FMR LLC increased its stake in TriMas by 1.7% during the 3rd quarter. FMR LLC now owns 44,082 shares of the industrial products company’s stock valued at $1,125,000 after purchasing an additional 729 shares in the last quarter. Institutional investors own 99.42% of the company’s stock.

Insider Buying and Selling at TriMas

In other news, Director Jeffrey A. Fielkow acquired 2,500 shares of the business’s stock in a transaction that occurred on Friday, February 28th. The stock was bought at an average price of $20.78 per share, with a total value of $51,950.00. Following the completion of the acquisition, the director now directly owns 11,013 shares of the company’s stock, valued at approximately $228,850.14. The trade was a 29.37 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Shawn Sedaghat bought 554,149 shares of the stock in a transaction on Monday, March 10th. The stock was purchased at an average cost of $24.07 per share, for a total transaction of $13,338,366.43. Following the acquisition, the director now owns 900,974 shares of the company’s stock, valued at $21,686,444.18. This trade represents a 159.78 % increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have purchased 806,246 shares of company stock worth $19,338,213. Company insiders own 1.10% of the company’s stock.

TriMas Stock Up 0.5 %

TriMas stock opened at $23.33 on Friday. TriMas Co. has a 12 month low of $19.33 and a 12 month high of $28.51. The stock has a fifty day simple moving average of $23.76 and a two-hundred day simple moving average of $25.00. The company has a current ratio of 2.83, a quick ratio of 1.44 and a debt-to-equity ratio of 0.60. The firm has a market cap of $946.80 million, a price-to-earnings ratio of 36.45 and a beta of 0.65.

TriMas Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 28th were given a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a yield of 0.69%. The ex-dividend date of this dividend was Friday, February 28th. TriMas’s dividend payout ratio (DPR) is 27.12%.

Analysts Set New Price Targets

Separately, BWS Financial reiterated a “buy” rating and set a $40.00 price target on shares of TriMas in a report on Friday, February 28th.

Read Our Latest Report on TRS

TriMas Company Profile

(Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Read More

Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Co. (NASDAQ:TRSFree Report).

Institutional Ownership by Quarter for TriMas (NASDAQ:TRS)

Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.